A follow-up on SYNTAX, the results of the FREEDOM trial and the FIRST study were among the developments covered at the SCAI 2013 Scientific Sessions' "Hottest Topics 2013" discussion, writes SCAI fellow Dr. Dmitriy Feldman. Keynote addresses at SCAI 2013 tackled FDA policies on clinical trials and device approvals and how they may affect the country's position as a leader in medical research, writes SCAI fellow Dr. Anita Asgar. A Town Hall session left attendees with a number of take-home messages, including that "clinicians, who share similar goals as the FDA, must play an important role in collaborating with not only the medical device industry, but also with the FDA to improve clinical trials and remain at the forefront of medical device innovation," she writes.

Related Summaries